GlassScriptPhysician profile
Ilse Anderson
NPI 1558330936
$1,696.38
in general payments reported to CMS, 2019-2025
18 companies · $423 in 2025
The $423 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $34.56 · 2021: $222 · 2022: $229 · 2023: $242 · 2024: $172 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816 · Education: $20.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.66 |
| Education | $20.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $629.29 | 2021-2025 | Valtoco |
| Alnylam Pharmaceuticals INC. | $237.97 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $153.72 | 2025 | Wainua |
| Grifols USA, LLC | $108.72 | 2019-2020 | |
| Ucb, INC. | $99.10 | 2022-2025 | Nayzilam, Fintepla, Briviact |
| Genzyme Corporation | $63.79 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $55.92 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $52.05 | 2021-2023 | |
| Alexion Pharmaceuticals, INC. | $49.14 | 2019-2023 | Strensiq |
| Biogen, INC. | $40.17 | 2019-2021 | |
| Immedica Pharma US, INC. | $38.01 | 2023-2024 | |
| Kyowa Kirin, INC. | $35.63 | 2023-2024 | Crysvita |
| Rhythm Pharmaceuticals, INC. | $30.57 | 2022 | |
| Akcea Therapeutics, INC. | $27.20 | 2019 | |
| Amicus Therapeutics, INC. | $26.15 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mirum Pharmaceuticals, INC. | $19.39 | 2025 | Cholbam |
| Acadia Pharmaceuticals INC | $15.82 | 2024 | Daybue |
| Arbor Pharmaceuticals, INC. | $13.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilse Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.